Downloadable Slidesets

Share

Program Content

Activities

  • Biomarkers and MRD in AML
    When and How to Assess Genomic and Molecular Alterations in AML: Which Mutations Matter?
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • AML Targeted Agents
    Available and Emerging Treatment Options in FLT3-Mutant and IDH-Mutant AML
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • Treating Newly Diagnosed AML
    Overcoming Treatment Challenges With New Targeted Agents and Formulations
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2019

    Expires: December 04, 2020

  • Immunotherapy in AML
    New Advances in Antibody–Drug Conjugates and Other Immunotherapeutic Agents
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2019

    Expires: December 07, 2020

Faculty

cover img faculity

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Actinium

Boston Biomedical

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Partners

NCCN

ProCE Banner